Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$2.48M Buy
68,808
+15,368
+29% +$512K 2.53% 15
2017
Q2
$1.68M Sell
53,440
-46,000
-46% -$1.43M 2.09% 18
2017
Q1
$3.15M Buy
99,440
+11,440
+13% +$339K 1.75% 14
2016
Q4
$2.54M Buy
88,000
+8,000
+10% +$225K 1.61% 12
2016
Q3
$2.25M Buy
+80,000
New +$2.19M 1.55% 30
2015
Q3
Sell
-63,600
Closed -$1.34M 74
2015
Q2
$1.34M Sell
63,600
-54,400
-46% -$1.14M 0.78% 50
2015
Q1
$2.41M Hold
118,000
1.35% 25
2014
Q4
$2.31M Buy
+118,000
New +$2.13M 1.3% 31

Other funds holding CTAS

Caldwell & Orkin's CTAS Position: Q3 2017 in Review

Caldwell & Orkin increased its Cintas (CTAS) stake by 29% in Q3 2017, buying an estimated $512K and bringing the position to 68,808 shares worth $2.48M. The position accounts for 2.53% of the portfolio, ranked #15.

Caldwell & Orkin first reported a position in CTAS in Q4 2014 and has held it in 8 quarters since. The position peaked at $3.15M in Q1 2017. 559 funds tracked by Wall St. Rank hold CTAS as of Q3 2017.

  • Caldwell & Orkin held 68,808 shares of Cintas worth $2.48M as of Q3 2017.
  • Caldwell & Orkin bought 15,368 Cintas shares in Q3 2017, an estimated $512K.
  • Cintas made up 2.53% of Caldwell & Orkin's portfolio in Q3 2017, its #15 holding.
  • Caldwell & Orkin first reported a position in Cintas in Q4 2014 and has held it in 8 quarters since.
  • Caldwell & Orkin's Cintas position peaked at $3.15M in Q1 2017.
  • 559 funds tracked by Wall St. Rank held Cintas as of Q3 2017.

Based on Caldwell & Orkin's 13F filing for Q3 2017, filed 7 Nov 2017.